Composition
- Active ingredients
- TILDRAKIZUMAB-ASMN 100MG/1ML
Official product information
Drugs@FDA lists the approved labels, letters and reviews for application BLA761067.
Prognia shows this product information for reference and learning. It is not treatment advice and can lag behind the official text. Always check the current product information and local protocols before prescribing.
At a glance
- Brand name
- Ilumya
- Active substance
- tildrakizumab-asmn
- Route
- Injection
- Dosage form
- Injectable
- Applicant
- Sun Pharma Global
- Status
- Prescription
- FDA approval
- 20 Mar 2018
- Application
- BLA761067-001